Skip to main content
letter
. 2022 Mar 14;84(6):834–872. doi: 10.1016/j.jinf.2022.03.011

Fig. 1.

Fig 1

. A Association between canakinumab treatment and mortality, Fig. 1B. Association between canakinumab treatment and developing severe COVID-19, Fig. 1C Association between canakinumab treatment and CRP levels.